Thus, for both T1D and T2D, strategies for regeneration of functional β-cell mass should ideally address all of the contributory elements of β-cell failure, including susceptibility to cytotoxic agents, loss of proliferative capacity, and impairment of insulin secretion. This evidence concerns the gene INS and type 1 diabetes mellitus.